Immune checkpoint inhibitors (ICIs) are associated with side effects such as muscle wasting. Here, the authors discover that targeting cathepsin L not only suppresses ICI-induced CD8 + T cell-mediated muscle wasting but also enhances ICI anti-tumor efficacy.
- Se-Young Park
- Kyuwon Son
- Na-Young Song
